HFpEF: cardiovascular abnormalities not just comorbidities.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it.

1. Validation of heart failure algorithm for diagnosing heart failure with preserved ejection fraction: a meta-analysis.ESC heart failure · 2023
   Pooled it
2. The Protocol for the Multi-Ethnic, multi-centre raNdomised controlled trial of a low-energy Diet for improving functional status in heart failure with Preserved ejection fraction (AMEND Preserved).BMJ open · 2025
   Article
3. Rising arterial stiffness with accumulating comorbidities associates with heart failure with preserved ejection fraction.ESC heart failure · 2023
   Article
4. Role of Oxidative Stress in Diabetic Cardiomyopathy.Antioxidants (Basel, Switzerland) · 2022
   Review
5. Phenotyping heart failure using model-based analysis and physiology-informed machine learning.The Journal of physiology · 2021
   Article
6. Predictive Value of HFA-PEFF Score in Patients With Heart Failure With Preserved Ejection Fraction.Frontiers in cardiovascular medicine · 2021
   Article
7. High-Density Lipoprotein-Targeted Therapies for Heart Failure.Biomedicines · 2020
   Review
8. Administration of apo A-I (Milano) nanoparticles reverses pathological remodelling, cardiac dysfunction, and heart failure in a murine model of HFpEF associated with hypertension.Scientific reports · 2020
   Article
9. Skeletal Muscle Myopathy in Heart Failure: the Role of Ejection Fraction.Current cardiology reports · 2018
   Review
10. Clinical Phenotypes in Heart Failure With Preserved Ejection Fraction.Journal of the American Heart Association · 2016
    Review
11. Heart failure preserved ejection fraction (HFpEF): an integrated and strategic review.Heart failure reviews · 2015
    Review
12. Pathophysiology and the cardiorenal connection in heart failure. Circulating hormones: biomarkers or mediators.Clinica chimica acta; international journal of clinical chemistry · 2015
    Review
13. Exploring Guidelines for Classification of Major Heart Failure Subtypes by Using Machine Learning.Clinical Medicine Insights. Cardiology · 2015
    Article
14. Diastolic dysfunction.Circulation journal : official journal of the Japanese Circulation Society · 2015
    Review
15. Heart failure with preserved ejection fraction.Journal of geriatric cardiology : JGC · 2013
    Review
16. Biomarkers of diastolic dysfunction and myocardial fibrosis: application to heart failure with a preserved ejection fraction.Journal of cardiovascular translational research · 2013
    Review
17. Management protocols for chronic heart failure in India.Indian heart journal
    Review
18. Non-invasive intraventricular pressure differences estimated with cardiac MRI in subjects without heart failure and with heart failure with reduced and preserved ejection fraction.Open heart
    Article

Corrections and comments

• Comment on
  Comorbidity and ventricular and vascular structure and function in heart failure with preserved ejection fraction: a community-based study.2012

Authors and funding

2 authors.

Funding

Abstract

PubMed holds no abstract for this paper.

Indexed as